CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply...

Request:  A global pharmaceutical sponsor conducting a Phase III clinical trial required Semaglutide, a GLP-1 receptor agonist, as a...

We are excited to announce that CSI will be attending the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas,...

Exciting news! CSI will be exhibiting at GCSG Asia Pacific 2024 this week, on March 12-13 in Seoul! Visit us at Table 7 to learn how our...

A Leading Biotech Client's Challenge A leading biotech client approached CSI to assist in sourcing the comparator drug Lucentis for a...

We’re excited to announce that Stephan Muetze , Director of Project Management, and Yasmine Clemson , Project Management and Marketing...

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

At Clinical Services International (CSI), we continually strive to exceed the expectations of our pharmaceutical and biotech partners by...